Cite
MLA Citation
R. Westhovens et al.. “THU0191 Novel formulation of ct-p13 for subcutaneous administration in patients with rheumatoid arthritis: initial results from a phase i/iii randomised controlled trial.” Annals of the rheumatic diseases, vol. 77, n.d., p. 315. http://access.bl.uk/ark:/81055/vdc_100144721172.0x000051